Triumeq
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AR - Combinations -> J05AR13 - Triumeq
Administration category:
Free
Medicine group:
antiviral
Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 1pieces 1 dd |
||
|
Comments:
Triumeq bestaat uit abacavir 600 mg +lamivudine 300 mg +dolutegravir 50 mg. |
||||
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 30 - 50 |
Dosage: niet toedienen |
|||
|
GFR: <30 |
Dosage: niet toedienen |
|||
Renal elimination:
abacavir: 83%, lamivudine: 70% dolutegravir: 32%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: niet gebruiken
Hemo dialysis: niet gebruiken
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-287597.1
Updated: 06/16/2019 - 20:05
Status: Published